CONTEXT THERAPEUTICS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
CONTEXT THERAPEUTICS INC. (CNTX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 154.96 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-05
- CONTEXT THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 55.03K shares, a 90.00% decline year-over-year.
- CONTEXT THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 99.93K shares.
- CONTEXT THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 0.00 shares.
- CONTEXT THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 139.48K shares.
- CONTEXT THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 689.77K shares, a 410.87% increase from fiscal 2024.
- CONTEXT THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 135.02K shares, a 6.64% increase from fiscal 2023.
- CONTEXT THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 126.61K shares, a 129.19% increase from fiscal 2022.
- CONTEXT THERAPEUTICS INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 55.24K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 55.03K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | 154.96K shares 10-Q · filed 2026-08-05 | 154.96K shares derived: sum of 3 quarters · filed 2026-08-05 | 294.44K shares derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 99.93K shares 10-Q · filed 2026-05-06 | 99.93K shares derived: sum of 2 quarters · filed 2026-05-06 | 239.41K shares derived: sum of 3 quarters · filed 2026-05-06 | 789.70K shares derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-23 | 139.48K shares derived: sum of 2 quarters · filed 2026-03-23 | 689.77K shares derived: sum of 3 quarters · filed 2026-03-23 | 689.77K shares 10-K · filed 2026-03-23 |
| 2025-09-30 | 139.48K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 689.77K shares derived: sum of 2 quarters · filed 2025-11-05 | 689.77K shares 10-Q · filed 2025-11-05 | 689.77K shares derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | 550.30K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | 550.30K shares 10-Q · filed 2025-08-06 | 550.30K shares derived: sum of 3 quarters · filed 2025-08-06 | 550.30K shares derived: sum of 4 quarters · filed 2025-08-06 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-07 | 0.00 shares derived: sum of 2 quarters · filed 2025-05-07 | 0.00 shares derived: sum of 3 quarters · filed 2025-05-07 | 24.35K shares derived: sum of 4 quarters · filed 2025-05-07 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 0.00 shares derived: sum of 2 quarters · filed 2025-03-20 | 24.35K shares derived: sum of 3 quarters · filed 2025-03-20 | 135.02K shares 10-K · filed 2025-03-20 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 24.35K shares derived: sum of 2 quarters · filed 2024-11-06 | 135.02K shares 10-Q · filed 2024-11-06 | 209.60K shares derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | 24.35K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | 135.02K shares 10-Q · filed 2024-08-07 | 209.60K shares derived: sum of 3 quarters · filed 2024-08-07 | |
| 2024-03-31 | 110.67K shares 10-Q · filed 2024-05-08 | 185.24K shares derived: sum of 2 quarters · filed 2024-05-08 | ||
| 2023-12-31 | 74.58K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 126.61K shares 10-K · filed 2024-03-21 | ||
| 2023-09-30 | 52.04K shares 10-Q · filed 2023-11-09 | |||
| 2023-03-31 | 0.00 shares 10-Q · filed 2023-05-10 | 0.00 shares derived: sum of 2 quarters · filed 2023-05-10 | ||
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | 55.24K shares 10-K · filed 2023-03-22 | ||
| 2022-09-30 | 55.24K shares 10-Q · filed 2022-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |